Trial intelligence / Profile preview

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for uncomplicated falciparum malaria in Kenyan children

NL-OMON28974Not yet recruiting

Sponsor
Royal Tropical Institute
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in Malaria comparing Coartem arm with Artekin arm (2 arms). Primary endpoint: Adequate clinical and parasitological response. Planned start Mar 2007; status: not yet recruiting.

02

Drugs

lumefantrinedihydroartemisinin + piperaquine
03

Conditions

Malaria

Beyond the preview

Go deeper on NL-OMON28974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON28974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call